Lavie Bio, A Subsidiary Of Evogene Received A Grant From The Israel Innovation Authority To Advance Its Program To Develop A Technology For The Delivery Of Ag-biologicals To Agriculture
Portfolio Pulse from Benzinga Newsdesk
Lavie Bio, a subsidiary of Evogene, received a grant from the Israel Innovation Authority to advance its 'MicroFermentor' technology for delivering ag-biologicals. This technology aims to reduce costs and extend the viability of beneficial bacteria in agriculture.
September 30, 2024 | 11:16 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Evogene's subsidiary, Lavie Bio, received a grant to develop 'MicroFermentor' technology, which could enhance agricultural efficiency and reduce costs, potentially boosting Evogene's market position.
The grant supports the development of a promising technology that could reduce costs and improve efficiency in agriculture, potentially increasing Evogene's revenue and market share. The positive initial results and the move towards commercialization suggest a favorable short-term impact on Evogene's stock.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80